ORIFLAME SWISS HOLDING AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - SEK | -.--% |
|
-.--% | +14.44% |
| Apr. 23 | Transcript : Oriflame Swiss Holding AG, Q1 2024 Earnings Call, Apr 23, 2024 | |
| Feb. 21 | Transcript : Oriflame Swiss Holding AG, Q4 2023 Earnings Call, Feb 21, 2024 |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,840 | 1,044 | 1,221 | 1,221 | 1,221 | 1,221 |
| Enterprise Value (EV) 1 | 1,835 | 1,173 | 1,348 | 1,760 | 1,863 | 1,902 |
| P/E ratio | 21.3 x | 11.5 x | 4.92 x | - | 1,134,991 x | -16,588 x |
| Yield | 4.64% | 8.29% | - | - | - | - |
| Capitalization / Revenue | 1.35 x | 0.82 x | 0.97 x | 1.06 x | 1.2 x | 1.32 x |
| EV / Revenue | 1.35 x | 0.92 x | 1.07 x | 1.52 x | 1.83 x | 2.06 x |
| EV / EBITDA | 10.4 x | 6.9 x | 8.91 x | 13.2 x | 11 x | 27.2 x |
| EV / FCF | 20.2 x | 8.49 x | 12.1 x | 11.4 x | 64.8 x | 54 x |
| FCF Yield | 4.94% | 11.8% | 8.28% | 8.75% | 1.54% | 1.85% |
| Price to Book | 8.67 x | 8.07 x | 2.46 x | - | 2,591 x | 2,819 x |
| Nbr of stocks (in thousands) | 53,376 | 54,122 | 56,624 | 56,624 | 56,624 | 56,624 |
| Reference price 2 | 34.47 | 19.29 | 21.56 | 21.56 | 21.56 | 21.56 |
| Announcement Date | 4/10/18 | 4/15/19 | 4/17/20 | 4/20/22 | 4/20/22 | 4/21/23 |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,363 | 1,279 | 1,258 | 1,157 | 1,016 | 925.4 |
| EBITDA 1 | 176.8 | 170 | 151.3 | 133.6 | 169.6 | 69.86 |
| EBIT 1 | 159 | 153.1 | 133.8 | 103.7 | 145 | 49.48 |
| Operating Margin | 11.67% | 11.97% | 10.63% | 8.97% | 14.27% | 5.35% |
| Earnings before Tax (EBT) 1 | 133.2 | 134.9 | 77.99 | 23.06 | 35.87 | -42.99 |
| Net income 1 | 92.55 | 95.43 | 43.79 | 0.279 | 0.712 | -48.37 |
| Net margin | 6.79% | 7.46% | 3.48% | 0.02% | 0.07% | -5.23% |
| EPS 2 | 1.620 | 1.680 | 4.379 | - | 0.000019 | -0.001300 |
| Free Cash Flow 1 | 90.68 | 138.2 | 111.6 | 154 | 28.74 | 35.25 |
| FCF margin | 6.65% | 10.81% | 8.87% | 13.31% | 2.83% | 3.81% |
| FCF Conversion (EBITDA) | 51.28% | 81.31% | 73.78% | 115.29% | 16.95% | 50.46% |
| FCF Conversion (Net income) | 97.98% | 144.8% | 254.87% | 55,192.38% | 4,037.18% | - |
| Dividend per Share 2 | 1.600 | 1.600 | - | - | - | - |
| Announcement Date | 4/10/18 | 4/15/19 | 4/17/20 | 4/20/22 | 4/20/22 | 4/21/23 |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 129 | 127 | 539 | 642 | 681 |
| Net Cash position 1 | 4.5 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 0.7577 x | 0.8404 x | 4.035 x | 3.788 x | 9.754 x |
| Free Cash Flow 1 | 90.7 | 138 | 112 | 154 | 28.7 | 35.3 |
| ROE (net income / shareholders' equity) | 42.7% | 53.5% | 39.3% | 0.14% | 0.22% | -16.3% |
| ROA (Net income/ Total Assets) | 13.4% | 13.2% | 11.8% | 6% | 6.34% | 2.25% |
| Assets 1 | 688.3 | 725.7 | 369.6 | 4.647 | 11.23 | -2,152 |
| Book Value Per Share 2 | 3.980 | 2.390 | 8.770 | - | 0.0100 | 0.0100 |
| Cash Flow per Share 2 | 3.970 | 3.160 | 14.30 | - | 0 | 0 |
| Capex 1 | 15.6 | 14.7 | 15.2 | 6.94 | 8.13 | 9.61 |
| Capex / Sales | 1.14% | 1.15% | 1.21% | 0.6% | 0.8% | 1.04% |
| Announcement Date | 4/10/18 | 4/15/19 | 4/17/20 | 4/20/22 | 4/20/22 | 4/21/23 |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- ORI Stock
- Financials Oriflame Swiss Holding AG
